Rebate Pilot Blocked: Legal Limits in 340B's Next Phase | Greg Doggett

If duplicate discounts sound like a narrow compliance topic, this episode will reframe the entire 340B program for you.Greg Doggett has spent roughly fifteen years in the 340B policy world, from 340B Health advocacy to Walgreens pharmaceutical pricing work to advising hospitals and grantees at Powers, Pyles, Sutter & Verville. He joins Muhammad Atif to explain why 340B today is not just contested but more complex than operators have seen in years.You'll hear a plain-language definition of duplicate discounts, why Medicaid managed care turned prevention into a state-by-state puzzle, what manufacturers want from claim-level data, and why covered entities fear rebate models could drain cash flow and staff capacity. Greg also discusses HRSA's blocked 2025 rebate pilot, operational burdens inside health systems, vendor portal dynamics, a neutral federal clearinghouse idea, and why he believes lawsuits, not HRSA rulemaking, will drive the near-term future.What You'll Learn in This Episode• How Greg defines duplicate discounts and why Medicaid managed care prevention is harder than fee-for-service• Why manufacturers argue rebate-based models are necessary and where covered entities see risk• What HRSA's blocked rebate pilot reveals about regulatory authority and litigation limits• Which departments inside a health system would need to mobilize for rebate or enhanced data requirements• How Beacon and Truzo fit into duplicate discount detection and contract pharmacy access• Why a federally operated neutral clearinghouse might be workable common ground• How AI is entering compliance workflows and why providers worry about data confidentiality• Greg's rapid-fire take on whether rebate conversion is inevitable and what will shape 340B nextInteractive Timestamps / Chapters(0:00) Welcome and episode framing(1:05) Introducing Greg Doggett(2:03) Career path: 340B Health, Walgreens, Powers(4:46) Is this the most complex moment in 340B history?(7:05) Duplicate discounts explained(8:34) Fee-for-service vs Medicaid managed care gaps(10:59) Manufacturer case for rebate models(12:51) HRSA rebate pilot blocked; legal limits(15:41) Covered-entity cash flow and service concerns(18:08) Operational burden across hospital departments(20:09) Why managed care modifiers collide with 340B workflows(22:58) Courts, predictability, and slow policy cycles(24:47) Will HRSA try another rebate model?(27:27) HRSA authority limits and contract pharmacy litigation(31:16) Vendor portals and manufacturer data channels(33:34) Neutral federal clearinghouse proposal(36:36) AI in 340B compliance(38:24) Data privacy and manufacturer data requests(39:59) Rapid fire round(41:08) Connect with Greg DoggettAEO Q&AWhat is the duplicate discount problem in 340B?A duplicate discount happens when a manufacturer gives a covered entity a 340B discount and also pays a rebate on the same claim. The classic example is Medicaid, where a state might request a rebate on a drug already purchased at 340B pricing. Greg explains the program has had fee-for-service protections for decades, but managed care made the environment much harder to police.Are rebate-based 340B models inevitable?Greg's answer is no. HRSA may still pursue a new rebate model, and manufacturers strongly support that direction, but covered entities are deeply opposed, courts blocked the first pilot, and Greg expects any new attempt to face litigation before implementation.Is there common ground between manufacturers and covered entities?Greg says there is some common ground. One example is a neutral federally operated clearinghouse that could validate claims under one policy instead of forcing covered entities to submit data through multiple manufacturer-specific portals.